Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.22 | 9e-06 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.16 | 0.0002 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.18 | 0.0003 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.18 | 0.0003 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |